Cadence Capital Management’s Mesa Laboratories MLAB Stock Holding History

Cadence Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$464K	Sell	1,820 -6,114	-77%	-$1.45M	0.11%	144
2020 Q2	$1.72M	Buy	7,934 +335	+4%	+$77.2K	0.25%	109
2020 Q1	$1.72M	Sell	7,599 -398	-5%	-$98.2K	0.29%	84
2019 Q4	$1.99M	Sell	7,997 -1,462	-15%	-$342K	0.21%	139
2019 Q3	$2.25M	Buy	+9,459	New	+$2.19M	0.32%	115

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Cadence Capital Management's MLAB Position: Q3 2020 in Review

Cadence Capital Management reduced its Mesa Laboratories (MLAB) stake by 77% in Q3 2020, selling an estimated $1.45M and leaving 1,820 shares worth $464K. The position accounts for 0.11% of the portfolio, ranked #144.

Cadence Capital Management first reported a position in MLAB in Q3 2019 and has held it in 5 quarters since. The position peaked at $2.25M in Q3 2019. 153 funds tracked by Wall St. Rank hold MLAB as of Q3 2020.

Cadence Capital Management held 1,820 shares of Mesa Laboratories worth $464K as of Q3 2020.
Cadence Capital Management sold 6,114 Mesa Laboratories shares in Q3 2020, an estimated $1.45M.
Mesa Laboratories made up 0.11% of Cadence Capital Management's portfolio in Q3 2020, its #144 holding.
Cadence Capital Management first reported a position in Mesa Laboratories in Q3 2019 and has held it in 5 quarters since.
Cadence Capital Management's Mesa Laboratories position peaked at $2.25M in Q3 2019.
153 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.